Staphylococcus aureus Penicillin-Binding Protein 2 Can Use Depsi-Lipid II Derived from Vancomycin-Resistant Strains for Cell Wall Synthesis.

about

Deciphering the mode of action of cell wall-inhibiting antibiotics using metabolic labeling of growing peptidoglycan in Streptococcus pyogenes.

P2860

Q41770204-0C3769CE-B86A-4D65-AE04-AA7CCD02E79F

P2860

Staphylococcus aureus Penicillin-Binding Protein 2 Can Use Depsi-Lipid II Derived from Vancomycin-Resistant Strains for Cell Wall Synthesis.

Item

http://www.wikidata.org/entity/Q38313962

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Staphylococcus aureus Penicill ...... rains for Cell Wall Synthesis.

@en

type

Item

label

Staphylococcus aureus Penicill ...... rains for Cell Wall Synthesis.

@en

prefLabel

Staphylococcus aureus Penicill ...... rains for Cell Wall Synthesis.

@en

P1476

Staphylococcus aureus Penicill ...... rains for Cell Wall Synthesis.

@en

P2093

Hideki Maki

http://www.w3.org/2001/XMLSchema#string

Hidenori Yamashiro

http://www.w3.org/2001/XMLSchema#string

Hirokazu Arimoto

http://www.w3.org/2001/XMLSchema#string

Hiroto Miya

http://www.w3.org/2001/XMLSchema#string

Jun Nakamura

http://www.w3.org/2001/XMLSchema#string

Kenzo Nishiguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications

Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)

Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

Kinetic characterization of the glycosyltransferase module of Staphylococcus aureus PBP2.

Transferable vancomycin and teicoplanin resistance in Enterococcus faecium.

Structure, biochemistry and mechanism of action of glycopeptide antibiotics.

Monofunctional transglycosylases are not essential for Staphylococcus aureus cell wall synthesis.

N-methylimidazolium chloride-catalyzed pyrophosphate formation: application to the synthesis of Lipid I and NDP-sugar donors.

Thermodynamics of interactions of vancomycin and synthetic surrogates of bacterial cell wall.

P304

12104-12112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CHEM.201301074

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

250925220

http://www.w3.org/2001/XMLSchema#string

P698

23873669

http://www.w3.org/2001/XMLSchema#string

P921

cell wall

P932

4235313

http://www.w3.org/2001/XMLSchema#string

Staphylococcus aureus Penicillin-Binding Protein 2 Can Use Depsi-Lipid II Derived from Vancomycin-Resistant Strains for Cell Wall Synthesis.

about

P2860

P2860

Staphylococcus aureus Penicillin-Binding Protein 2 Can Use Depsi-Lipid II Derived from Vancomycin-Resistant Strains for Cell Wall Synthesis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932